The US Food and Drug Administration approved the drug after trials showed a lower rate of relapse in chronic inflammatory demyelinating polyneuropathy or withdrawal for any other reason.
In a new statement, the FDA shared its plan to drastically reduce the nicotine levels in combustible tobacco products as part of its ongoing public health campaign.
In a new statement, the FDA shared its plan to drastically reduce the nicotine levels in combustible tobacco products as part of its ongoing public health campaign.
In a new statement, the FDA shared its plan to drastically reduce the nicotine levels in combustible tobacco products as part of its ongoing public health campaign.
In 2006, the US Food and Drug Administration issued an advisory that warned of the risk for serotonin syndrome with concomitant use of triptans and certain antidepressants. In a recent study, researchers...
In 2006, the US Food and Drug Administration issued an advisory that warned of the risk for serotonin syndrome with concomitant use of triptans and certain antidepressants. In a recent study, researchers...
